Outsmarting the Deadliest Brain Cancer
Glioblastoma is the most prevalent, hardest to treat and deadliest of all cancers that begin in the brain. About 25% of patients with glioblastoma survive two years after their diagnosis. Fewer than 5% survive five years, and fewer than 1% survive 10 years. Northwestern researchers have shed new light on the disease, brought new technologies to patients and even developed promising therapies that could revolutionize glioblastoma treatment — and cancer care more broadly.
Reader Responses
No one has commented on this page yet.
Submit a Response